Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Lavin

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The New England Journal of Medicine|March 21, 2014
Multitarget stool DNA testing for colorectal-cancer screeningThomas F Imperiale, David F Ransohoff, Steven H Itzkowitz, et al.
JAMA|November 18, 2014
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trialMikhail Kosiborod, Henrik S Rasmussen, Philip Lavin, et al.
Critical Care Medicine|August 31, 2022
The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled TrialJihad Georges Youssef, Philip Lavin, David A Schoenfeld, et al.
British Journal of Sports Medicine|October 17, 2018
Altered brain microstructure in association with repetitive subconcussive head impacts and the potential protective effect of jugular vein compression: a longitudinal study of female soccer athletesGregory D Myer, Kim Barber Foss, Staci Thomas, et al.
Pathology Oncology Research : POR|April 7, 2025
Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma -the <i>IT-MATTERS</i> studyEyal Talor, József Tímár, Philip Lavin, et al.
Neurological Research and Practice|December 16, 2020
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)Kathrin Reetz, Ralf-Dieter Hilgers, Susanne Isfort, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The New England Journal of Medicine|March 21, 2014
Multitarget stool DNA testing for colorectal-cancer screeningThomas F Imperiale, David F Ransohoff, Steven H Itzkowitz, et al.
JAMA|November 18, 2014
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trialMikhail Kosiborod, Henrik S Rasmussen, Philip Lavin, et al.
Critical Care Medicine|August 31, 2022
The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled TrialJihad Georges Youssef, Philip Lavin, David A Schoenfeld, et al.
British Journal of Sports Medicine|October 17, 2018
Altered brain microstructure in association with repetitive subconcussive head impacts and the potential protective effect of jugular vein compression: a longitudinal study of female soccer athletesGregory D Myer, Kim Barber Foss, Staci Thomas, et al.
Pathology Oncology Research : POR|April 7, 2025
Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma -the <i>IT-MATTERS</i> studyEyal Talor, József Tímár, Philip Lavin, et al.
Neurological Research and Practice|December 16, 2020
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)Kathrin Reetz, Ralf-Dieter Hilgers, Susanne Isfort, et al.
Pageof 2